Invivyd Inc reports results for the quarter - Earnings Summary

Invivyd

14/11/2024 20:59

* Invivyd Inc  IVVD.OQ  reported a quarterly adjusted loss
of 51
cents​​ per share for the quarter , lower than the same quarter
last year, when the company reported EPS of -36 cents.  The mean
expectation of four analysts for the quarter was for a loss
of 34 cents per share. Wall Street expected results to range
from -39 cents to -26 cents per share.
    * Revenue was $9.30 million​; analysts expected $27.25
million. 
    * Invivyd Inc's reported EPS for the quarter was a loss
of 51
cents​.
    * The company reported a quarterly loss of $60.74 million.
    * Invivyd Inc shares had fallen by 12.7% this quarter and
lost 77.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Invivyd Inc is
9.00 
This summary was machine generated from LSEG data November 14 at
08:59 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.34          -0.51          Missed
 Jun. 30 2024      -0.37          -0.40          Missed
 Mar. 31 2024      -0.47          -0.38          Beat
 Dec. 31 2023      -0.42          -0.67          Missed